Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
The importance of providing post-treatment care to cancer survivors
Cancer Survivorship
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM
Cancer Care in Older Adults and Special Population
The clinical impact of the Choosing Wisely project
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
Applying the syndemic framework to cancer research for effective cancer control in LMICs
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients